<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Journal of Advances in Medical and Biomedical Research</title>
<title_fa>Journal of Advances in Medical and Biomedical Research</title_fa>
<short_title>J Adv Med Biomed Res</short_title>
<subject>Medical Sciences</subject>
<web_url>http://journal.zums.ac.ir</web_url>
<journal_hbi_system_id>52</journal_hbi_system_id>
<journal_hbi_system_user>journal52</journal_hbi_system_user>
<journal_id_issn>1606-9366</journal_id_issn>
<journal_id_issn_online>2676-6264</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.30699/jambr</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1405</year>
	<month>3</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2026</year>
	<month>6</month>
	<day>1</day>
</pubdate>
<volume>2026</volume>
<number>Articles In Press</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Central Diabetes Insipidus in a Patient with Acute Myeloid Leukemia: A Case Report</title>
	<subject_fa>Clinical Medicine</subject_fa>
	<subject>Clinical Medicine</subject>
	<content_type_fa>گزارش موردی</content_type_fa>
	<content_type>Case Report Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;span style=&quot;line-height:150%&quot;&gt;&lt;span style=&quot;text-autospace:none&quot;&gt;&lt;span style=&quot;font-size:12.0pt&quot;&gt;&lt;span style=&quot;line-height:150%&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;Central diabetes insipidus (CDI) is an uncommon but potentially life-threatening complication in patients with hematologic malignancies. We report a case of a 30-year-old man who presented with upper respiratory symptoms, followed by progressive fatigue, polydipsia, and polyuria. Laboratory evaluation revealed pancytopenia, and bone marrow biopsy confirmed a diagnosis of AML-M2. Despite initial chemotherapy, the patient experienced persistent polyuria and hypernatremia (148&amp;ndash;156 mmol/L). Endocrine evaluation revealed urine osmolality of 159 mOsm/kg, serum osmolality of 298 mOsm/kg and a desmopressin challenge confirmed CDI (&gt;50% increase in urine osmolality). MRI demonstrated loss of the posterior pituitary bright spot and deviation of the pituitary stalk. The patient was treated with intranasal desmopressin, with symptomatic improvement. Despite therapy, the leukemia proved refractory, and the patient eventually succumbed to his illness. This case underscores the importance of early recognition of CDI in patients with AML, as timely diagnosis and management can mitigate severe complications.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&amp;nbsp;&lt;/div&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>acute myeloid leukemia, central diabetes insipidus, polyuria</keyword>
	<start_page>2</start_page>
	<end_page>2</end_page>
	<web_url>http://journal.zums.ac.ir/browse.php?a_code=A-10-7137-3&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Nasrin</first_name>
	<middle_name></middle_name>
	<last_name>Gholami</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>Gholamin@tbzmed.ac.ir</email>
	<code>5200319475328460088329</code>
	<orcid>5200319475328460088329</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. https://orcid.org/0000-0002-9546-0186</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Shalaleh</first_name>
	<middle_name></middle_name>
	<last_name>Aghaei</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>shalalehaghaei@gmail.com</email>
	<code>5200319475328460088330</code>
	<orcid>5200319475328460088330</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. https://orcid.org/0000-0002-5968-7033</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Gholamreza</first_name>
	<middle_name></middle_name>
	<last_name>Ravaei</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>gholamrezaravaei3@gmail.com</email>
	<code>5200319475328460088331</code>
	<orcid>5200319475328460088331</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. https://orcid.org/0009-0002-2101-7955</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
